Your browser doesn't support javascript.
loading
Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Leidner, Rom; Crittenden, Marka; Young, Kristina; Xiao, Hong; Wu, Yaping; Couey, Marcus A; Patel, Ashish A; Cheng, Allen C; Watters, Amber L; Bifulco, Carlo; Morris, George; Rushforth, Lessli; Nemeth, Shorin; Urba, Walter J; Gough, Michael; Bell, R Bryan.
Afiliación
  • Leidner R; Providence Cancer Institute, Portland, Oregon, USA.
  • Crittenden M; Earle A Chiles Research Institute, Portland, Oregon, USA.
  • Young K; Providence Cancer Institute, Portland, Oregon, USA.
  • Xiao H; Earle A Chiles Research Institute, Portland, Oregon, USA.
  • Wu Y; Division of Radiation Oncology, The Oregon Clinic, Portland, Oregon, USA.
  • Couey MA; Providence Cancer Institute, Portland, Oregon, USA.
  • Patel AA; Earle A Chiles Research Institute, Portland, Oregon, USA.
  • Cheng AC; Division of Radiation Oncology, The Oregon Clinic, Portland, Oregon, USA.
  • Watters AL; Department of Pathology, Providence Health and Services- Oregon, Portland, Oregon, USA.
  • Bifulco C; Department of Pathology, Providence Health and Services- Oregon, Portland, Oregon, USA.
  • Morris G; Providence Cancer Institute, Portland, Oregon, USA.
  • Rushforth L; Providence Cancer Institute, Portland, Oregon, USA.
  • Nemeth S; Head and Neck Institute, Portland, Oregon, USA.
  • Urba WJ; Head and Neck Institute, Portland, Oregon, USA.
  • Gough M; Providence Cancer Institute, Portland, Oregon, USA.
  • Bell RB; Providence Cancer Institute, Portland, Oregon, USA.
J Immunother Cancer ; 9(5)2021 05.
Article en En | MEDLINE | ID: mdl-33963014

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Radiocirugia / Terapia Neoadyuvante / Carcinoma de Células Escamosas de Cabeza y Cuello / Nivolumab / Inhibidores de Puntos de Control Inmunológico / Neoplasias de Cabeza y Cuello / Inmunoterapia Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Radiocirugia / Terapia Neoadyuvante / Carcinoma de Células Escamosas de Cabeza y Cuello / Nivolumab / Inhibidores de Puntos de Control Inmunológico / Neoplasias de Cabeza y Cuello / Inmunoterapia Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos